Eganelisib

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/​Refractory AML

Near Add Your Location

  • Accepting patients
  • Show Principal Investigator

MDS Center of Excellence

  • Accepting patients
  • Show Principal Investigator

MDS Center of Excellence

Ohio State University Comprehensive Cancer Center
James Cancer Hospital and Solove Research Institute
Columbus, OH
  • Accepting patients
  • Show Principal Investigator

MDS Center of Excellence

  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator

MDS Center of Excellence

  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.